Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

How drugs decrease fracture risk: lessons from trials.

S R Cummings1

  • 1University of California, San Francisco, California 94105, USA. scummings@psg.ucsf.edu

Journal of Musculoskeletal & Neuronal Interactions
|March 11, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Previous fracture and subsequent fracture risk: a meta-analysis to update FRAX.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2023
Same author

Update of the fracture risk prediction tool FRAX: a systematic review of potential cohorts and analysis plan.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2022
Same author

Zoledronic acid reduces the rate of clinical fractures after surgical repair of a hip fracture regardless of the Pretreatment bone mineral density.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2021
Same author

Authors' response to KD Stathopoulos regarding "Stop (Mis)classifying Fractures as High or Low Trauma or as Fragility Fractures".

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2021
Same author

Osteoporosis case ascertainment strategies in European and Asian countries: a comparative review.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2020
Same author

Explanations for the difference in rates of cardiovascular events in a trial of alendronate and romosozumab.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2020
Same journal

Commentary to: Relationship Between Plantar Pressure, Body Mass Index and Balance in Children: A Cross-Sectional Study.

Journal of musculoskeletal & neuronal interactions·2026
Same journal

Avascular Necrosis of the Femoral Head Following Posterior Hip Dislocation in an Adolescent.

Journal of musculoskeletal & neuronal interactions·2026
Same journal

Astragalus Polysaccharides Attenuate LPS-Induced Degenerative Responses in Primary Rat Chondrocytes linked to the NLRP3/CASPASE-1 Axis.

Journal of musculoskeletal & neuronal interactions·2026
Same journal

Quantitative Analysis of Spontaneous Tongue Muscle Reinnervation after Long Nerve Resection for Hypoglossal Nerve Injury in Rats.

Journal of musculoskeletal & neuronal interactions·2026
Same journal

Expression of miR-27a in Patients with Steroid-associated Femoral Head Osteonecrosis and Its Regulatory Mechanism on Proliferation and Osteogenic Differentiation of Bone Marrow Mesenchymal Stem Cells.

Journal of musculoskeletal & neuronal interactions·2026
Same journal

Effect of Sensory- Motor Integration Training on Activities of Daily Living in Children with Erb's Palsy: A Randomized Controlled Trial.

Journal of musculoskeletal & neuronal interactions·2026
See all related articles

Bone density improvements from osteoporosis drugs don't fully explain fracture risk reduction. This suggests other drug mechanisms are at play, impacting long-term bone health and fracture prevention strategies.

Area of Science:

  • Osteoporosis research
  • Pharmacology
  • Bone biomechanics

Background:

  • Osteoporosis treatment aims to reduce fracture risk.
  • Bone Mineral Density (BMD) measured by DXA is a key metric.
  • Antiresorptive agents are commonly used for osteoporosis.

Purpose of the Study:

  • To investigate the discrepancy between BMD improvements and fracture risk reduction with osteoporosis medications.
  • To explore potential mechanisms beyond BMD changes that influence fracture risk.
  • To evaluate the long-term effects of osteoporosis treatments on bone strength.

Main Methods:

  • Analysis of randomized trials of antiresorptive agents (alendronate, raloxifene).
  • Comparison of expected fracture risk reduction based on BMD changes versus observed reductions.

Related Experiment Videos

  • Review of studies on the biomechanical effects of osteoporosis drugs on bone.
  • Examination of parathyroid hormone (PTH) effects on BMD and fracture risk.

    • Main Results:

    • Antiresorptive agents show greater fracture risk reduction than predicted by BMD improvements alone.
    • The discrepancy is most pronounced early in treatment and lessens over time.
    • DXA may underestimate changes in spinal trabecular bone density.
    • Prolonged inhibition of bone remodeling may lead to microdamage accumulation.
    • PTH's effect on fracture risk is better explained by BMD improvements.

    Conclusions:

    • Mechanisms beyond BMD changes significantly contribute to fracture risk reduction by antiresorptive agents.
    • Concerns exist regarding potential bone weakening from prolonged remodeling inhibition.
    • Sustained BMD increases from PTH may offer long-term fracture risk reduction.
    • Non-spine fracture risk is complex and not solely predicted by BMD changes.